Hurricane Capital Advisors’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
Other funds holding LYEL
MM
OP
Hurricane Capital Advisors's LYEL Position: Q1 2024 in Review
Hurricane Capital Advisors sold out of Lyell Immunopharma (LYEL) in Q1 2024, closing a stake of 533 shares — an estimated $20.7K sold.
Hurricane Capital Advisors first reported a position in LYEL in Q4 2023 and held it in 1 quarter. The position peaked at $20.7K in Q4 2023. 127 funds tracked by Wall St. Rank hold LYEL as of Q1 2024.
- Hurricane Capital Advisors reported no remaining Lyell Immunopharma position as of Q1 2024 after selling out during the quarter.
- Hurricane Capital Advisors sold 533 Lyell Immunopharma shares in Q1 2024, an estimated $20.7K.
- Hurricane Capital Advisors first reported a position in Lyell Immunopharma in Q4 2023 and held it in 1 quarter.
- Hurricane Capital Advisors's Lyell Immunopharma position peaked at $20.7K in Q4 2023.
- 127 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2024.
Based on Hurricane Capital Advisors's 13F filing for Q1 2024, filed 3 Nov 2026.